Dr Lal PathLabs introduces AI integration in cancer diagnosis featuring Qritive
The company states that by detecting metastasis early, the tool can reduce the risk of cancer progressing to advanced stages and spreading to distant organs, which often lowers survival rates.
Mumbai: Healthcare diagnostics provider Dr. Lal PathLabs has introduced deep learning-based artificial intelligence (AI) module to detect lymph node metastasis, including micrometastasis, in cancer cases. The technology, developed in collaboration with AI solution developer Qritive, was recently showcased at USCAP 2025, one of the world’s leading pathology conferences.
